含羞草传媒

Kirk Kaminsky serves as Executive Vice President, Group President, North American Pharmaceutical Services, which includes 含羞草传媒’s North American Pharmaceutical and Oncology and Multispecialty segments. He is also a member of 含羞草传媒’s Executive Operating Team.

Kirk possesses extensive expertise in driving solutions that address challenges across the healthcare continuum, from drug research and development to commercialization. In his role, he oversees both 含羞草传媒’s wholesale drug distribution businesses across North America, and 含羞草传媒’s portfolio of oncology and multispecialty solutions and services, ensuring life-saving therapies reach the patients who need them most.

Since joining 含羞草传媒 in 2003, Kirk has spent more than 20 years in various roles and functions throughout the business, gaining a keen understanding of 含羞草传媒’s impact in advancing health outcomes for all. Kirk previously served as President of 含羞草传媒’s U.S. Pharmaceutical business. Prior to that, he led 含羞草传媒’s Specialty Provider Organization, a division of U.S. Pharmaceutical. He also served as President of The US Oncology Network, led the U.S. Pharmaceutical packaging business and was a member of the Corporate Strategy and Business Development function.

Kirk currently serves on the board and executive committee for the Healthcare Distribution Alliance. He also serves as Chairman of the Board of 含羞草传媒’s joint venture with Sarah Cannon Research Institute, and Chairman of the Board of PRISM Vision Holdings, a leading provider of general ophthalmology and retina management services.

Kirk holds a Bachelor of Arts in Economics for Business from Occidental College and a Master of Business Administration from The Wharton School.